title: 5-year Angiographic and Clinical Follow-up of Coil-embolised Intradural Saccular Aneurysms. A Single Center Experience.
abstract: The purpose of the paper is the follow-up of embolised intradural saccular Arterial Aneurysms (AA), excluding giant, dissecting, inflammatory, fusiform or AA associated to BVAM. Since its introduction in 1991, the Guglielmi Detachable Coil has offered protection against aneurysmal rebleeding in the critical few days and months after SAH regardless of the grade. A number of questions remain: is complete angiographic obliteration necessary at first embolisation? What duration of clinical / angiographic follow-up (FU) is required to ensure the risk of haemorrhage has been eliminated? What is the long-term protection against rebleeding? One hundred and two patients with 160 intradural saccular AA embolised before april 1997 were selected for this study. They had at least 5-yrs clinical FU, of which 22 patients had a mid- term (3 years) and 45 patients had a 5-year or more angiographic FU (mean 67,7 months per patient). Twenty-eight embolised AAs with 100% occlusion at 1 year, remained unchanged on the 5-year angiograms. A further 14 patients with complete occlusion at 1 year showed persisting complete occlusion on angiogram at 3-years FU, which in our series means that complete occlusion after the first year post-embolisation implies that the aneurysm will remain completely occluded. All secondary spontaneous thromboses (27.6% of cases), occurred during the first year pos- embolisation. In six patients with subtotal or partial occlusion no change was seen for three consecutive years of FU; none showed later change at 5-year angiography. Below 80% occlusion our series does not provide enough information but we consider the situation instable. No mortality related to the procedure was observed in the unruptured AA group.No bleeding or re-bleeding has occurred since the beginning of our experience (1993) in saccular AA treated by GDC-Coil. Coil-embolisation of properly selected patients is effective in protecting against bleeding or re-bleeding at short and long-term with stable morphological results provided a strict follow-up control is established at short term.
authors.affiliation: Service de Neuroradiologie Vasculaire Diagnostique et Thérapeutique, CHU de Bicêtre, Le Kremlin-Bicêtre; France - laeciolb@uol.com.br.
authors.forename: L L
authors.initials: LL
authors.lastname: Batista
authors.forename: J
authors.initials: J
authors.lastname: Mahadevan
authors.forename: M
authors.initials: M
authors.lastname: Sachet
authors.forename: H
authors.initials: H
authors.lastname: Alvarez
authors.forename: G
authors.initials: G
authors.lastname: Rodesch
authors.forename: P
authors.initials: P
authors.lastname: Lasjaunias